Alnylam Pharmaceuticals (ALNY) Enterprise Value (2009 - 2026)
Alnylam Pharmaceuticals (ALNY) posted Enterprise Value of $33 billion for Q3 2026, down 42.5% from $57.37 billion a year earlier and down 10.7% from the prior quarter.
Powered by 
Analysis
Alnylam Pharmaceuticals (ALNY) Enterprise Value (2009 - 2026) Analysis & Trends
For FY2025, Alnylam Pharmaceuticals' Enterprise Value came in at $49.73 billion, up 79.3% from FY2024.
- Annual Enterprise Value shows a five-year compound annual growth rate of 30.2% (FY2020 to FY2025).
- In prior years, Alnylam Pharmaceuticals' Enterprise Value was $27.74 billion in FY2024 (+28.1%), $21.65 billion in FY2023 (-20.7%), $27.28 billion in FY2022 (+51.5%) and $18.01 billion in FY2021 (+35.4%).
- The Q3 2026 figure stands as the lowest quarterly Enterprise Value since Q1 2025.
- On a year-over-year basis, Enterprise Value increased in six of the last eight quarters, with growth averaging 37.0%.
- The strongest year-over-year quarter for Enterprise Value in the past five years was Q1 2025, with growth of 96.9%; the weakest was Q3 2026, with a decline of 42.5%.
- According to Business Quant data, Enterprise Value for the three prior quarters was $36.95 billion (Q2 2026), $41.14 billion (Q1 2026) and $49.73 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Alnylam Pharmaceuticals | 20.30 Bn | 7.49 Bn | 1.10 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 29.45 Bn |
| Jun 30, 2026 | 36.95 Bn |
| Mar 31, 2026 | 41.14 Bn |
| Dec 31, 2025 | 49.73 Bn |
| Sep 30, 2025 | 57.37 Bn |
| Jun 30, 2025 | 39.85 Bn |
| Mar 31, 2025 | 32.56 Bn |
| Dec 31, 2024 | 27.74 Bn |
| Sep 30, 2024 | 32.66 Bn |
| Jun 30, 2024 | 28.49 Bn |
| Mar 31, 2024 | 16.54 Bn |
| Dec 31, 2023 | 21.65 Bn |
| Sep 30, 2023 | 19.82 Bn |
| Jun 30, 2023 | 21.69 Bn |
| Mar 31, 2023 | 22.84 Bn |
| Dec 31, 2022 | 27.28 Bn |
| Sep 30, 2022 | 22.38 Bn |
| Jun 30, 2022 | 15.57 Bn |
| Mar 31, 2022 | 17.51 Bn |
| Dec 31, 2021 | 18.01 Bn |
API Access
Alnylam Pharmaceuticals Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=ALNY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "ALNY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=ALNY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();